VTN and coronary atherosclerosis: Vitronectin levels have been shown to correlate with the extent of coronary atherosclerosis [39], to be higher in patients with acute coronary syndromes [40] and be an independent risk factor for adverse cardiovascular events in patients undergoing percutaneous cardiac interventions [41].